Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Shares of Novavax Inc. NVAX slid 2.86% to $12.56 Wednesday, on what proved to be an all-around dismal trading session for the ...

Moderna's decision to cut R&D by $1.1 billion signals reduced confidence in its Covid business and/or its pipeline. Learn ...

Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you need to know.

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

The stock market “can’t win” at the moment, said Andrew Brenner, head of international fixed income at National Alliance Securities. “Heads I lose, tails I lose.” Data delayed at least ...

Novavax's stock has been surging this year after announcing news of a collaboration with Sanofi. The company recently reported a profit, but whether it can stay out of the red is still a big ...

And since 2022, a sell-off has ensued, with the stock losing more than 91% of its value. Recently, there's been some renewed excitement in Novavax, however, and its shares are up over 150% this year.

Intel shares tumbled Tuesday amid worries the stock could be in danger of losing its status as a member of the Dow Jones Industrial Average (DJIA). The chipmaker's stock has fallen nearly 60% ...

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and said the vaccine is ready to ship. Novavax received the green light from ...